STELLENCE PHARMSCIENCE

Bengaluru, India Founded: 1992 • Age: 34 yrs
An RD-focused company specializing in manufacturing drugs for various therapeutic areas.
Request Access
Report Incorrect Data
Data last updated

About STELLENCE PHARMSCIENCE

STELLENCE PHARMSCIENCE is a Healthcare company based in Bengaluru (India) founded in 1992. It operates as an an RD-focused company specializing in manufacturing drugs for various therapeutic areas. It operates on a B2B model. The company has 103 employees. Its Indian entity Stellence Pharmscience Private Limited reported revenue of ₹29.16 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and R&D Services.

Company details

STELLENCE PHARMSCIENCE, established in 1992, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and providing RD services. An RD-focused company specializing in manufacturing drugs for various therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

Operational Areas
Healthcare → Pharmaceuticals & Distribution
Key Metrics
  • Annual Revenue
    ₹29.16 Cr

    FY 2022 · -16% YoY

  • Net Loss
    -₹5.88 Cr

    FY 2022 · -20% margin

  • EBITDA
    ₹4.48 Cr

    FY 2022 · 15% margin

  • Employee Count
    103

Board of directors of Stellence Pharmscience Private Limited (STELLENCE PHARMSCIENCE)

Stellence Pharmscience Private Limited is the primary company behind STELLENCE PHARMSCIENCE. The board of Stellence Pharmscience Private Limited currently have 5 directors; the longest-serving is Ramachandran Radhakrishnan, appointed in 2006. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ramachandran Radhakrishnan
DIN 00326368
Managing Director23 Aug 200620 yrs 1 moStellence Pharmscience Private Limited
Anuradha Ramachandran
DIN 00326388
Director15 May 20197 yrs 5 moStellence Pharmscience Private Limited
Akash Mathur
DIN 06883085
Director01 Apr 20206 yrs 6 moStellence Pharmscience Private Limited
Lalit Kumar Yadav
DIN 07874159
Director01 Apr 20206 yrs 6 moStellence Pharmscience Private Limited
Naveen Kumar Jain
DIN 02478555
IRP/RP/Liquidator16 Jul 20242 yrs 3 moStellence Pharmscience Private Limited

Financials of STELLENCE PHARMSCIENCE

Figures of Stellence Pharmscience Private Limited, the primary company behind STELLENCE PHARMSCIENCE, for FY 2022. Revenue was ₹29.16 Cr (-16% year on year). Net loss was -₹5.88 Cr (-20% margin). EBITDA was ₹4.48 Cr (15% margin). Revenue has grown at a compounded annual rate of +23% over three years and -8% over five years.

  • ₹29.16 CrRevenue · FY 2022 · -16% YoY
  • -₹5.88 CrNet loss · -20% margin
  • ₹4.48 CrEBITDA · 15% margin
  • ₹43.00 CrPaid-up capital
  • 103Employees (provident fund records)
  • +23%Revenue CAGR, 3 years
  • -8%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Stellence Pharmscience Private Limited are on its company page.

Premium access

Detailed financial statements for STELLENCE PHARMSCIENCE

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as STELLENCE PHARMSCIENCE (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Merck
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Roivant Sciences
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Amgen
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
AbbVie
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Lilly
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Gilead
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Recursion Pharmaceuticals
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
FibroGen
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 215.5 MUSD 29.62 M225
Abbott
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
MedPlus
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about STELLENCE PHARMSCIENCE

STELLENCE PHARMSCIENCE was founded in 1992.

STELLENCE PHARMSCIENCE is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

STELLENCE PHARMSCIENCE has 103 employees.

The primary company behind STELLENCE PHARMSCIENCE, Stellence Pharmscience Private Limited, reported revenue of ₹29.16 Cr for FY 2022, down 16% year on year.

STELLENCE PHARMSCIENCE, established in 1992, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and providing RD services. An RD-focused company specializing in manufacturing drugs for various therapeutic areas. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.

STELLENCE PHARMSCIENCE operates through Stellence Pharmscience Private Limited.

The legal entities of STELLENCE PHARMSCIENCE currently have 6 directors, including Naveen Kumar Jain, Ramachandran Radhakrishnan, Anuradha Ramachandran and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available